Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab

Gelijkaardige items

• Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors
  door: Payne, Amanda B., et al.
  Gepubliceerd in: (2019)
• Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen-Bethesda assay for factor VIII inhibitors
  door: Miller, C. H., et al.
  Gepubliceerd in: (2018)
• Comparison of Clot-based, Chromogenic, and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the U.S. Hemophilia Inhibitor Research Study
  door: Miller, Connie H., et al.
  Gepubliceerd in: (2013)
• Evaluation of pre-analytic heat treatment protocol used in the CDC Nijmegen-Bethesda assay for heat inactivation of extended half-life hemophilia treatment products
  door: Payne, Amanda B., et al.
  Gepubliceerd in: (2019)
• Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening
  door: Miller, Connie H., et al.
  Gepubliceerd in: (2015)